Kinetics of endogenous leukotriene B4 and E4 production following injection of the chemotactic peptide FMLP in the rabbit

Antonio Celardo, Giuseppe Dell'Elba, Stefano Manarini, Virgilio Evangelista, Giovanni De Gaetano, Chiara Cerletti

Research output: Contribution to journalArticle

Abstract

The kinetic profiles of leukotriene B4 (LTB4) and E4 (LTE4) after intravenous administration (30 nmol/kg) of the inflammatory peptide N- formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) were evaluated in male rabbits. LTB4 and LTE4 reached the maximal concentration of 84.2 ± 60.0 and 162.2 ± 51.4 nmol/L (mean ± s.d.), at 2 and 5 min, respectively. The first elimination phase for LTB4 and LTE4, after FMLP administration, showed an apparent half-life of 24.6 ± 6.7 and 36.9 ± 13.0 min, respectively. The area under the blood concentration-time curve (AUC, nmol min/L) of LTB4 and LTE4 was 2178 ± 1591 and 7627 ± 3052, respectively. LTE4 and N-ac-LTE4 were the major components excreted in the urine, mostly in the first time interval (0-12 h) of urinary collection after FMLP treatment; 11-trans-LTE4 was recovered in the second interval (12-24 h). Two other more polar compounds, potential metabolites, were recovered in the first interval of urine collection. Knowledge of the kinetic characteristics of endogenously produced leukotrienes may be useful in understanding the role of these eicosanoids in inflammatory and thrombotic disease, as well as in evaluating the efficacy of drugs designed to modulate their production and effect.

Original languageEnglish
Pages (from-to)699-711
Number of pages13
JournalProstaglandins
Volume54
Issue number4
DOIs
Publication statusPublished - Oct 1997

Fingerprint

leucyl-phenylalanine
Leukotriene E4
Leukotriene B4
Phenylalanine
Rabbits
Peptides
Injections
Kinetics
peptide L
Urine Specimen Collection
Eicosanoids
Leukotrienes
Metabolites
Intravenous Administration
Area Under Curve
Half-Life

Keywords

  • Chemotactic agent FMLP
  • Kinetics of endogenous leukotrienes
  • Leukotrienes
  • Peptidyl leukotrienes
  • Rabbit model of inflammation

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology

Cite this

Kinetics of endogenous leukotriene B4 and E4 production following injection of the chemotactic peptide FMLP in the rabbit. / Celardo, Antonio; Dell'Elba, Giuseppe; Manarini, Stefano; Evangelista, Virgilio; De Gaetano, Giovanni; Cerletti, Chiara.

In: Prostaglandins, Vol. 54, No. 4, 10.1997, p. 699-711.

Research output: Contribution to journalArticle

Celardo, Antonio ; Dell'Elba, Giuseppe ; Manarini, Stefano ; Evangelista, Virgilio ; De Gaetano, Giovanni ; Cerletti, Chiara. / Kinetics of endogenous leukotriene B4 and E4 production following injection of the chemotactic peptide FMLP in the rabbit. In: Prostaglandins. 1997 ; Vol. 54, No. 4. pp. 699-711.
@article{64a8eef48fea4785b867d7073aa4cdb1,
title = "Kinetics of endogenous leukotriene B4 and E4 production following injection of the chemotactic peptide FMLP in the rabbit",
abstract = "The kinetic profiles of leukotriene B4 (LTB4) and E4 (LTE4) after intravenous administration (30 nmol/kg) of the inflammatory peptide N- formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) were evaluated in male rabbits. LTB4 and LTE4 reached the maximal concentration of 84.2 ± 60.0 and 162.2 ± 51.4 nmol/L (mean ± s.d.), at 2 and 5 min, respectively. The first elimination phase for LTB4 and LTE4, after FMLP administration, showed an apparent half-life of 24.6 ± 6.7 and 36.9 ± 13.0 min, respectively. The area under the blood concentration-time curve (AUC, nmol min/L) of LTB4 and LTE4 was 2178 ± 1591 and 7627 ± 3052, respectively. LTE4 and N-ac-LTE4 were the major components excreted in the urine, mostly in the first time interval (0-12 h) of urinary collection after FMLP treatment; 11-trans-LTE4 was recovered in the second interval (12-24 h). Two other more polar compounds, potential metabolites, were recovered in the first interval of urine collection. Knowledge of the kinetic characteristics of endogenously produced leukotrienes may be useful in understanding the role of these eicosanoids in inflammatory and thrombotic disease, as well as in evaluating the efficacy of drugs designed to modulate their production and effect.",
keywords = "Chemotactic agent FMLP, Kinetics of endogenous leukotrienes, Leukotrienes, Peptidyl leukotrienes, Rabbit model of inflammation",
author = "Antonio Celardo and Giuseppe Dell'Elba and Stefano Manarini and Virgilio Evangelista and {De Gaetano}, Giovanni and Chiara Cerletti",
year = "1997",
month = "10",
doi = "10.1016/S0090-6980(97)00146-9",
language = "English",
volume = "54",
pages = "699--711",
journal = "Prostaglandins and Other Lipid Mediators",
issn = "1098-8823",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Kinetics of endogenous leukotriene B4 and E4 production following injection of the chemotactic peptide FMLP in the rabbit

AU - Celardo, Antonio

AU - Dell'Elba, Giuseppe

AU - Manarini, Stefano

AU - Evangelista, Virgilio

AU - De Gaetano, Giovanni

AU - Cerletti, Chiara

PY - 1997/10

Y1 - 1997/10

N2 - The kinetic profiles of leukotriene B4 (LTB4) and E4 (LTE4) after intravenous administration (30 nmol/kg) of the inflammatory peptide N- formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) were evaluated in male rabbits. LTB4 and LTE4 reached the maximal concentration of 84.2 ± 60.0 and 162.2 ± 51.4 nmol/L (mean ± s.d.), at 2 and 5 min, respectively. The first elimination phase for LTB4 and LTE4, after FMLP administration, showed an apparent half-life of 24.6 ± 6.7 and 36.9 ± 13.0 min, respectively. The area under the blood concentration-time curve (AUC, nmol min/L) of LTB4 and LTE4 was 2178 ± 1591 and 7627 ± 3052, respectively. LTE4 and N-ac-LTE4 were the major components excreted in the urine, mostly in the first time interval (0-12 h) of urinary collection after FMLP treatment; 11-trans-LTE4 was recovered in the second interval (12-24 h). Two other more polar compounds, potential metabolites, were recovered in the first interval of urine collection. Knowledge of the kinetic characteristics of endogenously produced leukotrienes may be useful in understanding the role of these eicosanoids in inflammatory and thrombotic disease, as well as in evaluating the efficacy of drugs designed to modulate their production and effect.

AB - The kinetic profiles of leukotriene B4 (LTB4) and E4 (LTE4) after intravenous administration (30 nmol/kg) of the inflammatory peptide N- formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) were evaluated in male rabbits. LTB4 and LTE4 reached the maximal concentration of 84.2 ± 60.0 and 162.2 ± 51.4 nmol/L (mean ± s.d.), at 2 and 5 min, respectively. The first elimination phase for LTB4 and LTE4, after FMLP administration, showed an apparent half-life of 24.6 ± 6.7 and 36.9 ± 13.0 min, respectively. The area under the blood concentration-time curve (AUC, nmol min/L) of LTB4 and LTE4 was 2178 ± 1591 and 7627 ± 3052, respectively. LTE4 and N-ac-LTE4 were the major components excreted in the urine, mostly in the first time interval (0-12 h) of urinary collection after FMLP treatment; 11-trans-LTE4 was recovered in the second interval (12-24 h). Two other more polar compounds, potential metabolites, were recovered in the first interval of urine collection. Knowledge of the kinetic characteristics of endogenously produced leukotrienes may be useful in understanding the role of these eicosanoids in inflammatory and thrombotic disease, as well as in evaluating the efficacy of drugs designed to modulate their production and effect.

KW - Chemotactic agent FMLP

KW - Kinetics of endogenous leukotrienes

KW - Leukotrienes

KW - Peptidyl leukotrienes

KW - Rabbit model of inflammation

UR - http://www.scopus.com/inward/record.url?scp=0031449883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031449883&partnerID=8YFLogxK

U2 - 10.1016/S0090-6980(97)00146-9

DO - 10.1016/S0090-6980(97)00146-9

M3 - Article

C2 - 9440133

AN - SCOPUS:0031449883

VL - 54

SP - 699

EP - 711

JO - Prostaglandins and Other Lipid Mediators

JF - Prostaglandins and Other Lipid Mediators

SN - 1098-8823

IS - 4

ER -